Exposure and coverage to routine schedule vaccines in different EU countries (ADVANCE-POC2)

Study type

• Study type:
  Non-interventional study
• Scope of the study:
  Drug utilisation

Non-interventional study

• Non-interventional study design:
  Cohort

Study drug and medical condition

• Anatomical Therapeutic Chemical (ATC) code:
  (J07B) VIRAL VACCINES

  VIRAL VACCINES

Population studied

• Age groups:
  Preterm newborn infants (0 – 27 days)

  Term newborn infants (0 – 27 days)

  Infants and toddlers (28 days – 23 months)

  Children (2 to < 12 years)

  Adolescents (12 to < 18 years)

  Adults (18 to < 46 years)

  Adults (46 to < 65 years)

  Adults (65 to < 75 years)

  Adults (75 to < 85 years)

  Adults (85 years and over)
• Estimated number of subjects:
  35000000

Study design details

• Main study objective:
  To assess exposure and coverage to routine vaccinations
• Outcomes:
  Counts and coverage, Comparisons against WHO benchmarks
• Data analysis plan:
  Exposure and coverage estimation using point prevalence, point prevalence adjusted for follow-up and cumulative distribution function